Immune Pharmaceuticals Inc (fka IMNPQ)

[Investor100]

Marketwatch @ IMNP

More exposure for IMNP

http://www.marketwatch.com/story/research-reports-coverage-on-healthcare-stocks----immune-pharma-sanofi-shire-and-universal-health-services-2016-09-09

Immune Pharma

New York headquartered Immune Pharmaceuticals Inc.'s stock finished Thursday's session 2.70% lower at $0.36. A total volume of 3.10 million shares was traded, which was above their three months average volume of 2.72 million shares. The Company's shares are trading below their 50-day moving average by 8.26%. Furthermore, shares of Immune Pharmaceuticals, which develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas, have a Relative Strength Index (RSI) of 45.66.

On September 7 [th] , 2016, Immune Pharmaceuticals announced that it has entered into a stock purchase agreement with an existing stockholder for the sale of 4,000,000 shares of its common stock at a fixed price of $0.50 per share, for gross proceeds of $2,000,000. The company noted that there are no warrants, no restrictive covenants, and no restrictions on use of proceeds. Your complete research report on IMNP can be retrieved for free at:

http://stock-callers.com/registration/?symbol=IMNP


Investor 100